Chronic Total Occlusion and Triglyceride-Glucose Index

ConditionsCAD - Coronary Artery Disease Chronic Total Occlusion (CTO)Triglycerid Glucose Index

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorKırıkkale University

About this trial

We retrospectively analyzed 200 CAD patients undergoing coronary angiography between 2026-2027. Patients were grouped by CTO presence. Clinical and laboratory parameters were compared, and logistic regression was performed to identify independent predictors.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Adults ≥18 years of age, patients undergoing coronary angiography, non-obese individuals

Disqualifiers

Patients <18 years of age, history of atrial fibrillation, pacemaker implantation, asthma, pulmonary hypertension, pregnancy, anemia, malignancy, rheumatoid arthritis, or peripheral artery disease, obesity (BMI >30 kg/m²), inaccessible patient records

Trial population

The study population will consist of adult patients (≥18 years of age) undergoing coronary angiography, who will be divided into two groups according to the presence or absence of chronic total occlusion (CTO).

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

triglyceride-glucose (TyG) index was calculated from routinely obtained blood samples using the formula: Triglyceride (mg/dL) × Glucose (mg/dL) / 2.
Diagnostic test
As no previous studies have demonstrated the predictive value of the TyG index for chronic total occlusion (CTO), the present investigation provides a novel contribution to the literature. We hypothesize that the triglyceride-glucose (TyG) index will be significantly higher in patients with chronic total occlusion (CTO) compared to those without CTO.

Treatment groups

200 Participants

are divided into 2 treatment groups

Group A: Non CTO1 intervention

Group B: CTO1 intervention

Trial outcomes

Primary outcomes

The primary outcome measure will be the difference in the triglyceride-glucose (TyG) index between patients with chronic total occlusion (CTO) and those without CTO, assessed from routinely obtained blood samples.

Time frame

1 Year

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kırıkkale University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: